Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Tirzepatide vs Semaglutide vs Retatrutide Semaglutide: Targets 1 receptor (GLP-1) commonly used as a first-line option Tirzepatide: Targets 2 receptors (GLP-1 + GIP) suitable for enhanced appetite control Retatrutide: Targets 3 receptors a newer, more advanced multi-pathway option Cost & Availability Typical cost: 400 per kit (approx
Journal of Clinical Medicine, 9(6), 1724
FDA labeling allows staying at the current dose for an extra 4 weeks before stepping up
( 3 ) In the SURMOUNT-4 trial, patients with obesity receiving tirzepatide had a mean 25.3% body weight loss over 88 weeks
Shapiro, Yuxing Dong, Ki-Chul Sung, Gregory Y
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
